source
- Multispecific drug design faces growing complexity as more binding arms increase molecular optionsThe industry is seeing a rapid rise in complex biologic formats such as trispecific antibodies and cell-engaging molecules. As these multispecific constructs multiply, drug developers are turning t…
- China proposes ban on biotech platform sales but keeps licensing deals openChinese ministries of Commerce and Science and Technology released a draft policy that would prohibit the transfer of ownership for five biotech technologies, including cell and gene therapy, small…